Loading clinical trials...
Loading clinical trials...
Despite combined antiretroviral therapy (cART), milder forms of HIV-associated neurocognitive disorders (HAND) persist in 20-50% of persons living with HIV (PLHIV). Since more PLH are at risk for HAND...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06095297 · Long COVID, Brain Fog, and more
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
Fondation Ophtalmologique A. de Rothschild /URC
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions